Jenish Christin: The Clot Buster That Buys Time in Critical Moments
Jenish Christin, Critical Care Nurse Specialist- CTICU of ABUAD Multi-System Hospital, shared a post on LinkedIn:
“Streptokinase: The Clot Buster That Buys Time in Critical Moments
When minutes matter… reperfusion saves myocardium.
What is Streptokinase?
A fibrinolytic (thrombolytic) agent derived from Streptococci that activates plasminogen – plasmin, leading to clot breakdown.
Clinical Scenario
A 58-year-old male presents with:
- Crushing chest pain
- ST-elevation on ECG
- No PCI facility available
Streptokinase becomes a lifesaving option
Mechanism of Action
Streptokinase forms a complex with plasminogen:
- Converts more plasminogen to plasmin
- Degrades fibrin clot
- Restores blood flow
Indications
- STEMI (when PCI unavailable)
- Massive Pulmonary Embolism
- Deep Vein Thrombosis (selected cases)
- Arterial thrombosis
Contraindications (HIGH-YIELD)
- Active internal bleeding
- Recent surgery/trauma
- Hemorrhagic stroke history
- Severe uncontrolled hypertension
Adverse Effects
- Bleeding (most serious)
- Hypersensitivity reactions (foreign protein!)
- Hypotension during infusion
Clinical Pearl
- Prior streptococcal infection or previous use equals antibody formation
- Reduced efficacy plus high risk of allergic reactions
Why not always Streptokinase?
Because newer agents (e.g., Alteplase) are:
- More fibrin-specific
- Faster acting
- Less antigenic
But In resource-limited settings, Streptokinase still saves lives daily
Bottom Line
Streptokinase may be old…
But in the right setting, at the right time – It’s the difference between life and death
Master the basics.
Save the critical.”
Stay updated with Hemostasis Today.
-
Jul 13, 2026, 23:39Yaariv Khaykin: Whole-Person Care Can Strengthen Stroke Prevention in Patients With Atrial Fibrillation
-
Jul 13, 2026, 22:33ESOC 2026 recordings are now available on eSTEP – European Stroke Organisation
-
Jul 13, 2026, 20:17Julia R. Coleman: Fantastic First Day at ISTH 2026
-
Jul 13, 2026, 20:11Ruah Alyamany: Combination Therapy Improves Quality of Life in ITP
-
Jul 13, 2026, 19:47Brian O Mahony: Two-Year Results of BBM-H901 Gene Therapy Presented at ISTH 2026
-
Jul 13, 2026, 19:37Sara Zalghout: Connecting With Colleagues From All Over the World at ISTH 2026
-
Jul 13, 2026, 18:54Alfonso J. Tafur: New Evidence on Perioperative Anticoagulation in Cancer at ISTH 2026
-
Jul 13, 2026, 18:42Jessica Garcia: Thrombin Generation in Type 3 VWD With an Inhibitor on Emicizumab
-
Jul 13, 2026, 18:19Fionnuala Ní Áinle: High-Quality Evidence for DVT Diagnosis in Pregnancy at ISTH 2026